X @Bloomberg
Bloomberg·2026-02-06 18:04
AgomAb Therapeutics, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, opened 8.1% below its IPO price on Friday after the firm raised $200 million in a listing https://t.co/bprXryMjj1 ...